Ocugen (OCGN) Operating Income Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.38% |
| Dec 31, 2025 | -34.87% |
| Sep 30, 2025 | -11.60% |
| Jun 30, 2025 | -32.59% |
| Mar 31, 2025 | -29.84% |
| Dec 31, 2024 | -26.46% |
| Sep 30, 2024 | -37.32% |
| Jun 30, 2024 | -46.00% |
| Mar 31, 2024 | -20.34% |
| Dec 31, 2023 | -15.16% |
| Sep 30, 2023 | -38.90% |
| Jun 30, 2023 | -26.44% |
| Mar 31, 2023 | -24.24% |
| Dec 31, 2022 | -31.09% |
| Sep 30, 2022 | -34.46% |
| Jun 30, 2022 | -27.62% |
| Mar 31, 2022 | -22.74% |
| Dec 31, 2021 | -13.01% |
| Sep 30, 2021 | -10.17% |
| Jun 30, 2021 | -26.34% |
| Mar 31, 2021 | 1.98% |
| Dec 31, 2020 | 14.46% |
| Sep 30, 2020 | -4.84% |
| Jun 30, 2020 | 15.02% |
| Mar 31, 2020 | 12.98% |
| Dec 31, 2019 | 8.13% |
| Sep 30, 2019 | 28.90% |
| Jun 30, 2019 | 17.27% |
| Mar 31, 2019 | 1.32% |